Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil
- PMID: 35196783
- PMCID: PMC8865440
- DOI: 10.1128/spectrum.02366-21
Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil
Abstract
The Amazonas was one of the most heavily affected Brazilian states by the COVID-19 epidemic. Despite a large number of infected people, particularly during the second wave associated with the spread of the Variant of Concern (VOC) Gamma (lineage P.1), SARS-CoV-2 continues to circulate in the Amazonas. To understand how SARS-CoV-2 persisted in a human population with a high immunity barrier, we generated 1,188 SARS-CoV-2 whole-genome sequences from individuals diagnosed in the Amazonas state from 1st January to 6th July 2021, of which 38 were vaccine breakthrough infections. Our study reveals a sharp increase in the relative prevalence of Gamma plus (P.1+) variants, designated Pango Lineages P.1.3 to P.1.6, harboring two types of additional Spike changes: deletions in the N-terminal (NTD) domain (particularly Δ144 or Δ141-144) associated with resistance to anti-NTD neutralizing antibodies or mutations at the S1/S2 junction (N679K or P681H) that probably enhance the binding affinity to the furin cleavage site, as suggested by our molecular dynamics simulations. As lineages P.1.4 (S:N679K) and P.1.6 (S:P681H) expanded (Re > 1) from March to July 2021, the lineage P.1 declined (Re < 1) and the median Ct value of SARS-CoV-2 positive cases in Amazonas significantly decreases. Still, we did not find an increased incidence of P.1+ variants among breakthrough cases of fully vaccinated patients (71%) in comparison to unvaccinated individuals (93%). This evidence supports that the ongoing endemic transmission of SARS-CoV-2 in the Amazonas is driven by the spread of new local Gamma/P.1 sublineages that are more transmissible, although not more efficient to evade vaccine-elicited immunity than the parental VOC. Finally, as SARS-CoV-2 continues to spread in human populations with a declining density of susceptible hosts, the risk of selecting more infectious variants or antibody evasion mutations is expected to increase. IMPORTANCE The continuous evolution of SARS-CoV-2 is an expected phenomenon that will continue to happen due to the high number of cases worldwide. The present study analyzed how a Variant of Concern (VOC) could still circulate in a population hardly affected by two COVID-19 waves and with vaccination in progress. Our results showed that the answer behind that was a new generation of Gamma-like viruses, which emerged locally carrying mutations that made it more transmissible and more capable of spreading, partially evading prior immunity triggered by natural infections or vaccines. With thousands of new cases daily, the current pandemics scenario suggests that SARS-CoV-2 will continue to evolve and efforts to reduce the number of infected subjects, including global equitable access to COVID-19 vaccines, are mandatory. Thus, until the end of pandemics, the SARS-CoV-2 genomic surveillance will be an essential tool to better understand the drivers of the viral evolutionary process.
Keywords: Brazil; COVID-19; SARS-CoV-2; coronavirus; variant gamma; virus evolution.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.Microbiol Spectr. 2022 Feb 23;10(1):e0151121. doi: 10.1128/spectrum.01511-21. Epub 2022 Feb 16. Microbiol Spectr. 2022. PMID: 35171035 Free PMC article.
-
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19).2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 34033342 Free Books & Documents.
-
Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak.Virol J. 2021 Nov 17;18(1):222. doi: 10.1186/s12985-021-01690-1. Virol J. 2021. PMID: 34789293 Free PMC article.
-
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.Front Med (Lausanne). 2022 May 20;9:849217. doi: 10.3389/fmed.2022.849217. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35669924 Free PMC article. Review.
-
Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination.J Med Virol. 2022 May;94(5):1815-1820. doi: 10.1002/jmv.27539. Epub 2021 Dec 31. J Med Virol. 2022. PMID: 34936124 Review.
Cited by
-
Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters.J Infect Dis. 2023 May 12;227(10):1143-1152. doi: 10.1093/infdis/jiac276. J Infect Dis. 2023. PMID: 35776136 Free PMC article.
-
SARS-CoV-2 Rapid Antigen Test Based on a New Anti-Nucleocapsid Protein Monoclonal Antibody: Development and Real-Time Validation.Microorganisms. 2023 Sep 28;11(10):2422. doi: 10.3390/microorganisms11102422. Microorganisms. 2023. PMID: 37894080 Free PMC article.
-
SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil.Sci Rep. 2023 May 5;13(1):7306. doi: 10.1038/s41598-023-33443-1. Sci Rep. 2023. PMID: 37147348 Free PMC article.
-
Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.Microbiol Spectr. 2022 Feb 23;10(1):e0151121. doi: 10.1128/spectrum.01511-21. Epub 2022 Feb 16. Microbiol Spectr. 2022. PMID: 35171035 Free PMC article.
-
Cocktail of REGN Antibodies Binds More Strongly to SARS-CoV-2 Than Its Components, but the Omicron Variant Reduces Its Neutralizing Ability.J Phys Chem B. 2022 Apr 21;126(15):2812-2823. doi: 10.1021/acs.jpcb.2c00708. Epub 2022 Apr 11. J Phys Chem B. 2022. PMID: 35403431 Free PMC article.
References
-
- Fundação de Vigilância em Saúde do Amazonas. 2021. Boletim diaria COVID-19 no Amazonas 15–06-2021. https://www.fvs.am.gov.br/noticias_view/6264. Accessed July 03, 2021.
-
- Naveca FG, Nascimento V, Souza VCd, Corado AL, Nascimento F, Silva G, Costa Á, Duarte D, Pessoa K, Mejía M, Brandão MJ, Jesus M, Gonçalves L, Costa CFd, Sampaio V, Barros D, Silva M, Mattos T, Pontes G, Abdalla L, Santos JH, Arantes I, Dezordi FZ, Siqueira MM, Wallau GL, Resende PC, Delatorre E, Gräf T, Bello G. 2021. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence. Nat Med 27:1230–1238. doi:10.1038/s41591-021-01378-7. - DOI - PubMed
-
- Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DDS, Mishra S, Crispim MAE, Sales FCS, Hawryluk I, McCrone JT, Hulswit RJG, Franco LAM, Ramundo MS, de Jesus JG, Andrade PS, Coletti TM, Ferreira GM, Silva CAM, Manuli ER, Pereira RHM, Peixoto PS, Kraemer MUG, Gaburo N, Jr, Camilo CDC, Hoeltgebaum H, Souza WM, Rocha EC, de Souza LM, de Pinho MC, Araujo LJT, Malta FSV, de Lima AB, Silva JDP, Zauli DAG, Ferreira ACS, Schnekenberg RP, Laydon DJ, Walker PGT, Schluter HM, Dos Santos ALP, Vidal MS, Del Caro VS, Filho RMF, Dos Santos HM, Aguiar RS, Proenca-Modena JL, Nelson B, Hay JA, Monod M, Miscouridou X, et al. . 2021. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science 372:815–821. doi:10.1126/science.abh2644. - DOI - PMC - PubMed
-
- Governo do Estado do Amazonas, Fundação de Vigilância em Saúde do Amazonas. 2021. Vacinômetro - COVID-19. https://www.fvs.am.gov.br/indicadorSalaSituacao_view/75/2. Accessed July 03, 2021.
Publication types
MeSH terms
Substances
Grants and funding
- LNCC
- E-26/202.896/2018/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- VPPCB-007-FIO-18-2-30/Fundação Oswaldo Cruz (FIOCRUZ)
- PCTI-EmergeSaude/Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM)
- Rede Genô/Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM)
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous